Brez internetne povezave — prikazana je shranjena različica strani.

Genmab A/S

DKDKK
← Na filter delnic

Genmab A/S (LSE:0MGB) — Biotechnology. Število borz, na katerih se trgujejo delnice družbe: 3. Na tej strani — cena in graf, dividende, največji imetniki in zgodovina števila delnic.

O podjetju

Spletna stran
genmab.com
Sektor
Healthcare · Biotechnology
Sedež
Copenhagen, Denmark
Izvršni direktor
Dr. Jan G.J. van de Winkel Ph.D.
Zaposleni
3 119
Na borzi od
05.11.2007 (LSE:0MGB)
Delnice v obtoku
61.49 mio.
Prosto prenosljive delnice
58.96 mio.
Tržna kapitalizacija
152.62 mrd. DKK
Notranje osebe
1.12%
Institucionalni vlagatelji
47.36%
Panoga (SIC)
Pharmaceutical Preparations
Opis

Genmab A/S, a biotechnology company, develops antibody-based products and product candidates for the treatment of cancer and other diseases in Denmark. The company markets EPKINLY and TEPKINLY for adult patients with relapsed or refractory (R/R) diffuse large b-cell lymphoma (DLBCL), large B-cell lymphoma, and follicular lymphoma (FL); and Tivdak for adult patients with recurrent/metastatic cervical cancer with disease progression on or after chemotherapy. It is also developing Epcoritamab for R/R DLBCL and FL, first line DLBCL and FL, B-cell non-Hodgkin lymphoma, R/R chronic lymphocytic leukemia and Richter's syndrome, and aggressive mature B-cell neoplasms in pediatric patients; tisotumab vedotin for solid tumors; Acasunlimab for solid tumors and non-small cell lung cancer (NSCLC); Rinatabart Sesutecan for platinum resistant ovarian cancer and solid tumors; GEN1059, GEN1055, and GEN1057 for solid tumors; and GEN1286 for advanced solid tumors. In addition, the company offers DARZALEX/DARZALEX FASPRO for multiple myeloma (MM) and light-chain Amyloidosis; RYBREVANT for NSCLC; TECVAYLI and TALVEY for R/R MM; Kesimpta for Relapsing multiple sclerosis; and TEPEZZA for thyroid eye disease. Further, it is developing Amivantamab for recurrent/metastatic head and neck cancer, and advanced or metastatic colorectal cancer; Amlenetug for multiple system atrophy; Inclacumab for vaso-occulsive crises in sickle cell diseases; and Mim8 for hemophilia A. The company has a collaboration agreement with AbbVie Inc., Pfizer Inc., BioNTech SE, Johnson & Johnson, Medarex, Inc., Bristol Myers Squibb Corporation, Lundbeck A/S, Amgen Inc., Novo Nordisk A/S, and argenx. Genmab A/S was incorporated in 1998 and is headquartered in Copenhagen, Denmark.

Borze in oznake

BorzaOznakaValutaCenaVrsta
CO Nasdaq CopenhagenGMAB glavnaDKK2 257 -2.42%navadne delnice
LSE London Stock Exchange0MGB IOBDKK2 613 +0.00%navadne delnice
US USA StocksGNMSF OTCUSD378 -4.78%navadne delnice

Cena v 3 mesecih

dan rasti dan padca ex-dividendni datum datum izplačilaPremaknite miško / tapnite dan — otvoritvena, zaključna, najvišja in najnižja cena

Dividende

Ni bilo najdenih izplačil dividend (preverjeno 09.10.2026). Podjetje verjetno ne izplačuje dividend.

Novice ta teden

Novic s spletnega mesta podjetja še ni.

oglas

Največji imetniki

ImetnikDeležDelniceDatum poročila
Paradigm Biocapital Advi…2.1%13.13 mio.2026-06-30
VANGUARD SPECIALIZED FUN…2.05%1.28 mio.2026-07-31
Orbis Allan Gray Ltd1.82%11.37 mio.2026-06-30
VANGUARD STAR FUNDS-Vang…1.41%882 7182026-07-31
Alliancebernstein L.P.1.39%8.64 mio.2026-06-30
Deerfield Management Com…1.1%6.87 mio.2026-06-30
VANGUARD WORLD FUND-Vang…1.05%653 2062026-05-31
VANGUARD TAX-MANAGED FUN…0.93%582 4772026-06-30
Deep Track Capital, Lp0.91%5.65 mio.2026-06-30
Arrowstreet Capital, Lim…0.8%4.98 mio.2026-06-30
Blackrock Inc.0.75%4.67 mio.2026-06-30
HARDING LOEVNER Fd.S INC…0.75%466 8172026-07-31
Bernstein Fund Inc-Inter…0.73%458 1602026-06-30
iShares Trust-iShares Co…0.72%452 3322026-08-31
Sofinnova Investments, I…0.65%4.05 mio.2026-06-30
iShares Trust-iShares Bi…0.63%3.91 mio.2026-08-31
Renaissance Technologies…0.56%3.52 mio.2026-06-30
Two Sigma Investments, L…0.56%3.51 mio.2026-06-30
First TRT Exch-Trd Fd.-F…0.5%3.12 mio.2026-08-31
Artisan Partners Funds I…0.44%276 4902026-06-30
Fidelity Concord Street…0.38%237 3282026-07-31
iShares Trust-iShares MS…0.34%210 5902026-08-31
American Century ETF Tru…0.09%546 7782026-08-31
Federated Hermes Equity…0.08%520 7002026-07-31
Federated Hermes Equity…0.06%350 0002026-07-31
Federated Hermes World I…0.06%343 7712026-06-30
RUSSELL INVESTMENT CO-Ta…0.05%342 3442026-07-31
Mercer Funds-Mercer Non-…0.03%179 6762026-06-30
SUNAMERICA SERIES TRUST-…0.03%161 3982026-07-31
Tema ETF Trust-Tema Onco…0.03%158 8612026-05-31
Pacer Advisors, Inc.0%582026-06-30